White House pushes Tylenol-autism claim
Trump and RFK Jr. told pregnant women to stop using acetaminophen, contradicting major medical bodies.
Key facts
- FDA urged physicians to minimize acetaminophen use in pregnancy
- Leucovorin approved only for rare cerebral folate deficiency, not autism
- Major medical bodies say evidence does not support causation
Summary
At a White House event, Trump and HHS Secretary RFK Jr. urged pregnant women to stop using acetaminophen, claiming it may cause autism, and the FDA urged physicians to minimize its use. Major medical bodies say the evidence does not support causation.
What happened
On September 22, 2025, Trump and RFK Jr. told pregnant women to stop using Tylenol, claiming it may cause autism, and the FDA sent physicians a letter urging minimized use. The same event oversold leucovorin as an autism treatment, but the FDA ultimately approved it only for the rare cerebral folate deficiency, not autism. Leading medical organizations say the evidence does not support a causal link between acetaminophen and autism. ER data later showed acetaminophen use among pregnant women dropped after the announcement.
Impact on the United States
Discourages pregnant Americans from using the safest available fever and pain reliever, while untreated high fever in pregnancy carries real risks; it also spreads a debunked autism cause from the federal podium and misleads autism families about an unproven treatment.
Documented effects
Why this is rated severe
The president and HHS secretary urged pregnant women to avoid acetaminophen over an autism link that major medical bodies say the evidence does not support, and emergency-department acetaminophen orders for pregnant patients fell 10% afterward.
Corrections & updates [6]
Every change to a fact on this page after publication is logged here, newest first.
- CorrectedDate
The FDA approved leucovorin for cerebral folate deficiency on March 10, 2026 (Scientific American, March 11, 2026), not in September 2025. The effect date and the source date are corrected.[2]
- ClarifiedSource
Adds a source for the statement that acetaminophen use among pregnant ER patients fell: NBC News reported a Lancet analysis finding orders fell 10% for pregnant patients visiting emergency departments after the announcement.[4]
- ClarifiedTitle
Title wording made neutral and aligned with the cited reporting (NBC News: 'unproven link').[1]
- Previously
- Trump, RFK Jr. push debunked Tylenol-autism link
- Now
- Trump, RFK Jr. push unproven Tylenol-autism link
- ClarifiedSummary card
The summary card said acetaminophen 'use' among pregnant women dropped. The Lancet analysis cited measured acetaminophen orders for pregnant patients visiting emergency departments, which fell 10% after the announcement.[1][4]
+ Show previous and current text- Hide previous and current text
- Previously
- At a September 22, 2025 White House event, Trump and RFK Jr. urged pregnant women to stop using Tylenol over an unproven autism link. The FDA pushed minimized use, and ER data later showed acetaminophen use among pregnant women dropped.
- Now
- At a September 22, 2025 White House event, Trump and RFK Jr. urged pregnant women to stop using Tylenol over an unproven autism link. The FDA pushed minimized use, and emergency-department acetaminophen orders for pregnant patients later fell 10%.
- ClarifiedSeverity rationale
The severity rationale called the claim 'debunked' and the drug 'the safest pregnancy fever reliever' without attribution; it now states the medical bodies' position and the documented effect. Severity unchanged.
+ Show previous and current text- Hide previous and current text
- Previously
- Federal podium spread a debunked autism cause, deterring use of the safest pregnancy fever reliever.
- Now
- The president and HHS secretary urged pregnant women to avoid acetaminophen over an autism link that major medical bodies say the evidence does not support, and emergency-department acetaminophen orders for pregnant patients fell 10% afterward.
- ClarifiedSource labels
Source tier labels brought in line with the site's tier rule (specialist and trade publications are Tier 3; general news organizations are Tier 2): Scientific American (Tier 2 to 3); STAT (Tier 2 to 3). No claim in the entry changed.
Sources [4]
- T2NBC News - With RFK Jr. behind him, Trump pushes unproven link between Tylenol and autism · Sep 22, 2025 ↗
- T3Scientific American - The FDA Approves Leucovorin for Rare Genetic Condition and Not for Autism · Mar 11, 2026 ↗
- T3STAT - FDA aims to expand use of leucovorin as RFK Jr. touts it as autism treatment · Sep 22, 2025 ↗
- T2NBC News - Tylenol orders for some pregnant women fell after Trump warned them not to take it · Mar 5, 2026 ↗
Image: U.S. Navy photo by Chief Warrant Officer 4 Seth Rossman., Public domain (Wikimedia Commons)
